Shinichi Saitoh

6PUBLICATIONS
10CO-AUTHORS
Innate immunityPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 25, 2023
Intracellular Major Histocompatibility Complex Class II and C-X-C Motif Chemokine Ligand 10-Expressing Neutrophils Indicate the State of Anti-Tumor Activity Induced by Bacillus Calmette-Guérin.

Yuji Takeda, Tomoyuki Kato, Saima Sabrina

|May 27, 2023
Hemoglobin β Expression Is Associated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Yuta Kurota, Yuji Takeda, Osamu Ichiyanagi

|May 27, 2023
Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma.

Saima Sabrina, Yuji Takeda, Tomoyuki Kato

|Jul 28, 2022
HDAC Class I Inhibitor Domatinostat Preferentially Targets Glioma Stem Cells over Their Differentiated Progeny.

Yurika Nakagawa-Saito, Shinichi Saitoh, Yuta Mitobe

|Nov 13, 2021
GPI-80 Augments NF-κB Activation in Tumor Cells.

Yuji Takeda, Yuta Kurota, Tomoyuki Kato

|Sep 28, 2021
Crosstalk between Metabolic Disorders and Immune Cells.

Shinichi Saitoh, Koen Van Wijk, Osamu Nakajima

Pageof 1

Frequent Collaborators

4 joint publications

Yuji Takeda

4 joint publications

Hironobu Asao

3 joint publications

Sei Naito

3 joint publications

Norihiko Tsuchiya